More Than Just Risk: Genetic Testing Is Shaping Breast Cancer Treatment

https://myriad.com/gene-results/BRCA1/1/

BRCA1 Gene Mutation Risk Test - Myriad Genetics

Men with BRCA1 mutations have an elevated risk for breast and prostate cancer. The increased risk for prostate cancer may be most significant at younger ages.

https://myriad.com/genetic-tests/bracanalysiscdx-germline-test/

BRACAnalysis CDx® Germline Companion Diagnostic Test

Pancreatic cancer. Prostate cancer. Deleterious or suspected deleterious mutations in BRCA1 and BRCA2 genes. LYNPARZA ^® (olaparib) ...

https://investor.myriad.com/news-releases/news-release-detail/12331/

Study Finds Wide Gap in Quality of BRCA1/2 Variant Classification ...

Apr 17, 2017 ... Dramatically declining VUS rates. Myriad has reduced the BRCA1/2 VUS rates from 40 percent to 1.6 percent, dramatically lower than any other ...

https://investor.myriad.com/news-releases/news-release-detail/11526/

THOSE WITH AN ALTERED BRCA1 OR BRCA2 GENE HAVE A 56 ...

According to estimates, women with an altered BRCA1 or BRCA2 gene have a 56 to 87 percent risk to develop breast cancer by age 70, whereas the risk for women in ...

https://myriad.com/patients-families/disease-info/breast-cancer/

Hereditary Breast Cancer | Myriad Genetics

Up to ten percent of breast cancer cases are caused by mutations in the BRCA1 or BRCA2 genes 3 , which can be inherited through generations of family members.

https://investor.myriad.com/news-releases/news-release-detail/10686/

Myriad Genetics' European Breast Cancer Patents Upheld by EPO

Myriad discovered the BRCA1 gene in 1994 and the BRCA2 gene in 1995. The Company developed a highly sophisticated laboratory process to analyze the genes for ...

https://myriad.com/mychoicecdx-astrazeneca/

MyChoice® CDx HRD Companion Diagnostic Test - Myriad Genetics

Retest your patients with advanced ovarian cancer who were negative for BRCA1/2 mutations at no added cost* · Knowing HRD status is important to determine ...

https://investor.myriad.com/news-releases/news-release-detail/10721/

Myriad Introduces Enhanced BRACAnalysis® Test for Exceptionally ...

Aug 1, 2006 ... The added test detects rare, large rearrangements of the DNA in the BRCA1 and BRCA2 genes and will be performed for women with exceptionally high risk.

https://myriad.com/oncology/bracanalysiscdx-patient-guide/

BRACAnalysis CDx® Guide for Patients - Myriad Genetics

What is BRCA1/2 and how does BRCA status influence my cancer treatment? Everyone is born with BRCA genes, and the proteins produced by the BRCA1 and BRCA2 ...

https://investor.myriad.com/news-releases/news-release-detail/11596/

Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials

Jun 19, 2007 ... ... BRCA1 & BRCA2 positive breast and ovarian cancer. AstraZeneca's ... BRCA1 or BRCA2. The BRCA1 and BRCA2 genes are involved in DNA ...